Navigation Links
Vaginal Mesh Lawsuit News: Wright & Schulte LLC Applauds Settlement of C.R. Bard Transvaginal Mesh Lawsuit
Date:8/25/2013

to warn of the potential risks associated with the mesh. (Queen v. C.R. Bard Inc., 11-cv-00012)

Many of her allegations were similar to those brought forth in the federal litigation’s first vaginal mesh trial, which Bard lost just a week prior. That transvaginal mesh lawsuit was filed on behalf of a woman who was injured by the Bard Avaulta Plus device, and who claimed that the company had knowingly used a plastic resin that was unfit for permanent implantation. According to court documents, the total judgment in that case included $250,000 in compensatory damages and $1.75 million in punitive damages. (Cisson v. C.R. Bard Inc., 11-cv-00195)

That trial marked the third loss in a row for transvaginal mesh manufacturers, and the second loss for C.R. Bard. Last July, the company was ordered to pay $3.6 million to another victim of Avaulta Plus in a case that went to trial in California Superior Court. (Scott v. Kannappan, S-1500-CV-266034-WDE ) In March, the New Jersey Superior Court jury hearing the nation’s first trial of an Ethicon Inc. transvaginal mesh lawsuit awarded more than $11 million to a woman injured by the Gynecare Prolift device. (Gross v. Gynecare Inc., Atl-L-6966-10)

In addition to the C.R. Bard litigation, several other multidistrict litigations are pending in the Southern District of West Virginia for vaginal mesh lawsuits involving other device manufacturers, including:

  • In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2325)
  • In re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation (MDL No. 2326);
  • In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2327)
  • In Re: Coloplast Corp. Pelvic Support System Products Liability Litigation (MDL No. 2387)

About Wright & Schulte LLC
Wright & Schulte LLC, a defective me
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Vaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Settlement in Second Bellwether Trial in Federal C.R. Bard Mesh Litigation
2. C.R. Bard Settles Its Second Transvaginal Mesh Case in West Virginia Multidistrict Litigation, Notes Parker Waichman LLP
3. Transvaginal Mesh Lawsuit Update: Rottenstein Law Group LLP Comments on Bard Mesh Trial Settlement in W. Va.
4. Transvaginal Mesh Device Caused California Woman Serious Injuries, Alleges Parker Waichman LLP in Lawsuit
5. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Start of Second Bellwether Trial in Federal C.R. Bard Litigation
6. Transvaginal Mesh Lawsuit News: New CR Bard Mesh Trial Scheduled for Aug. 19, Rottenstein Law Group LLP Reports
7. Vaginal Mesh Lawsuit News: Wright & Schulte LLC Applaud $2 Million Verdict in C.R. Bard Transvaginal Mesh Lawsuit Trial
8. Vaginal Mesh Lawsuits Proceed Against Ethicon, as Bernstein Liebhard LLP Notes Order for Discovery Conferences in Federal Ethicon Litigation
9. Vaginal Mesh Lawsuit News: Plaintiff in First Federal Bellwether Trial of C.R. Bard Vaginal Mesh Lawsuit Awarded $2 Million
10. Jury Awards Transvaginal Mesh Patient $2M, Finding that C.R. Bard Failed to Warn of the Dangers of Its Avaulta Pelvic Mesh Device, Notes Parker Waichman LLP
11. Vaginal Mesh Lawsuit News: Jury Awards $2 Million to Plaintiff in First C.R. Bard Vaginal Mesh Lawsuit, Reports Alonso Krangle LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... (HealthDay News) -- The quality of Americans, diets has ... between the rich and poor is growing, a new ... evidence to date that the extensive efforts by many ... having some payoff, but it also indicates that these ... a doctoral student in the department of nutrition at ...
(Date:9/2/2014)... Amy Norton HealthDay ... For people who want to lose weight and boost their ... trimming dietary fat, a new study suggests. In a ... assigned to follow a low-carbohydrate diet lost more weight over ... They also had bigger improvements in their cholesterol and triglyceride ...
(Date:9/2/2014)... 02, 2014 The Jerry Segal Classic ... on September 19 at The ACE Club and Green ... past 25 years, the Classic, organized by the Friends ... for programs and services designed to support patients and ... , “The Segal Classic is a labor of ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 North ... America Resectoscopes Market Outlook to 2020? provides key ... The report provides value, in millions of US ... US dollars) within market segments –, ... (Disposable and Reusable) Electrodes and Bipolar (Disposable and ...
(Date:9/2/2014)... Ohio (PRWEB) September 02, 2014 Humility of ... Home, Sept. 18 at St. Elizabeth Health Center, 1044 Belmont ... provides information about more than 200 common health problems as ... preventing illness and injury, and advice on when to seek ... a.m. to noon in the Youngstown Room; the evening session ...
Breaking Medicine News(10 mins):Health News:Quality of U.S. Diet Improves, Slightly 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 3Health News:The 25th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:North America Resectoscopes & Bronchoscopes Market (Revenue, Volume & Company Share) to 2020 Report Available at MarketOptimizer.org 2Health News:North America Resectoscopes & Bronchoscopes Market (Revenue, Volume & Company Share) to 2020 Report Available at MarketOptimizer.org 3Health News:North America Resectoscopes & Bronchoscopes Market (Revenue, Volume & Company Share) to 2020 Report Available at MarketOptimizer.org 4Health News:HMHP Offers ‘Health at Home’ Workshop 2
... Barcelona, Spain: An experimental drug that attacks cancer in ... advanced melanoma, delaying progression of the disease and prolonging ... (Wednesday) at the European Cancer Conference (ECCO 14) in ... to chemotherapy more than doubled the amount of time ...
... 26 Biomedtex Inc.,(Pink Sheets: PDNL.PK) ("Biomed" or ... that A. Marc Rocca, 42, will be,President and ... mission is to identify, evaluate and assess a ... and then,seek to capture and promote innovations with ...
... Nycomed Acquires Exclusive Rights Outside North America in Deal Valued ... ... N.J. and ZURICH, Switzerland, Sept. 26, NPS Pharmaceuticals, Inc. (Nasdaq: ... into a definitive agreement,which licenses to Nycomed the rights to ...
... research has yielded a clearer picture of which biomarkers ... colon cancer, bringing closer the day when patients who ... those that will, get the more aggressive treatment they ... doctors plan treatment of colon cancer chiefly by staging ...
... work investigating the reproducibility of glycemic index values, ... Research Center on Aging at Tufts University (USDA ... determinations (measure of the rate of glucose absorption ... white bread, resulted in a relatively high level ...
... to Home and the ... ... pioneer and largest provider of retail-,based health care in the United ... stores in Southeastern,Pennsylvania and Southern New Jersey. MinuteClinic plans to open ...
Cached Medicine News:Health News:New type of drug shows promise in attacking melanoma in an innovative way 2Health News:NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America 2Health News:NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America 3Health News:NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America 4Health News:Study makes progress in zoning in on biomarkers for better colon cancer treatment 2Health News:Glycemic index values are variable, report researchers 2Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Philadelphia Metro Area 2Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Philadelphia Metro Area 3Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Philadelphia Metro Area 4Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Philadelphia Metro Area 5
(Date:9/2/2014)... DIEGO , Sept. 2, 2014  Volcano ... company focused on improving patient and economic outcomes ... innovative minimally invasive coronary and peripheral visualization, physiology ... be participating in the Morgan Stanley Healthcare conference ... by Scott Huennekens , president and chief ...
(Date:9/2/2014)... Sept. 2, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... products marketed as XIAFLEX ® in the U.S. and ... President, Tom Wegman , will present at the following ... Rodman & Renshaw 16 th Annual ... Tuesday, September 9, 2014 at 9:10 a.m. EDT ...
(Date:9/2/2014)... , September 2, 2014 ... NASDAQ: EMITF ) announced today following the ... Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M), a subsidiary of ... a fully diluted basis, announced that on September 1, ... approximately 30.8% of the voting power ("Gamida Cell") and ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 3
... Phase IIa Trial Increase in Dendritic, ... BASKING RIDGE, N.J., Oct. 10 VioQuest,Pharmaceuticals ... company focused on acquiring, developing and,commercializing targeted ... enrollment in its Phase I open-label dose ...
... New Phase 3 Plan Could Expedite Clinical Development Pathway, ... (Nasdaq: ANSV ) today announced that it will ... Adlea(TM) -- one of which has already,been planned in ... in,bunionectomy surgeries -- for a broad product label of ...
Cached Medicine Technology:VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM) 2VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM) 3VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM) 4Anesiva Defines Regulatory Pathway for Adlea with FDA 2Anesiva Defines Regulatory Pathway for Adlea with FDA 3Anesiva Defines Regulatory Pathway for Adlea with FDA 4Anesiva Defines Regulatory Pathway for Adlea with FDA 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: